MedPath

Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women

Active, not recruiting
Conditions
Breast Cancer
Registration Number
NCT00900367
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about nutrition-related changes that identify biomarkers related to cancer. It may also help doctors predict a woman's risk of developing breast cancer.

PURPOSE: This laboratory study is looking at nutrition-related biomarkers in predicting breast cancer risk in women.

Detailed Description

OBJECTIVES:

* To complete characterization of metabolic serotypes based on the metabolome, and to adapt these profiles for human epidemiological studies.

* To determine the extent to which metabolic profiles that are reflective of or independent of long-term caloric intake predict breast cancer risk in nested case-control studies.

* To identify critical serum metabolites.

OUTLINE: Laboratory studies, including metabolome profiling by high performance liquid chromatography; and small molecule identification by mass spectroscopy, are performed on previously collected blood samples.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
1500
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Utility of metabolome profiles in predicting relative risk of developing breast cancerongoing
Utility of rat metabolome profiles for human epidemiological studiesongoing
Generation of metabolome profiles that reflect nutritional statusongoing
Identification of critical serum metabolitesongoing
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dana-Farber/Brigham and Women's Cancer Center

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath